IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

General Atlantic, L.P.

Q4 2024 Holdings

Filed 2025-02-07 | 16 holdings | $2.8B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Dlocal(DLO)CL AG29018101$719.6M63,906,69525.6%
Alignment Healthcare(ALHC)COM01625V104$686.2M60,993,32324.4%
Alkami(ALKT)COM01644J108$353.8M9,645,31812.6%
XP, Inc(XP)CL AG98239109$351.0M29,617,73312.5%
Centessa Pharmaceuticals(CNTA)ADS152309100$162.2M9,681,8185.8%
Akero Therapeutics(AKRO)COM00973Y108$145.6M5,233,9895.2%
Pharvaris(PHVS)COMN69605108$144.4M7,531,2525.1%
European WAX Center(EWCZ)CL A29882P106$87.4M13,110,4923.1%
Royalty Pharma(RPRX)CL AG7709Q104$38.3M1,500,0001.4%
Immunocore(IMCR)ADS45258D105$37.2M1,261,6841.3%
Third Harmonic BIO(THRD)COM88427A107$34.7M3,372,3231.2%
Riskified(RSKD)CL AM8216R109$25.2M5,324,9980.9%
AcelyrinCOM00445A100$8.5M2,695,3270.3%
Adagene(ADAG)ADS005329107$7.6M3,825,9520.3%
Wish(5ZZ0)CL A21077C305$4.3M609,6160.2%
Grove Collaborative(GROV)CL A39957D201$3.4M2,474,8590.1%